Hair Growth Powder 99% OC000459 CAS 851723-84-7 For Hair Loss Treatment
Place of Origin | China |
---|---|
Brand Name | XRD |
Certification | GMP |
Model Number | 851723-84-7 |
Minimum Order Quantity | negotiable |
Price | Inquiry for Negotiable |
Packaging Details | 1-2 kg / aluminum foil bag, 25kg/ drum, as required |
Delivery Time | 1-2days after payment received |
Payment Terms | T/T bank, Western Union, Bitcoin, Etc |
Supply Ability | 100KG/ Month |

Contact me for free samples and coupons.
Whatsapp:0086 18588475571
Wechat: 0086 18588475571
Skype: sales10@aixton.com
If you have any concern, we provide 24-hour online help.
xCAS | 851723-84-7 | Product Name | OC000459 |
---|---|---|---|
Type | Hair Growth Powder | Appearance | White Powder |
Usage | Hair Loss Treatment | Alias | OC000459 |
Assay | 99.2% | Key Words | OC000459 |
High Light | anti estrogen steroids,hair growth powder |
Hair Growth Powder 99% OC000459 CAS 851723-84-7 for Hair Loss Treatment
Product Details
Specification:99%
Boiling Point:574.416 °C at 760 mmHg
Flash Point:301.196 °C
Density: 1.297 g/cm3
MW:348.37
Appearance:White Powder
OC-000459; OC 000459;[5-Fluoro-2-methyl-3-(2-quinolinylmethyl)-1H-indol-1-yl]acetic acid;5-Fluoro-2-methyl-3-(2-quinolinylmethyl)-1H-indole-1-acetic acid.
OC-000459 for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of OC000459 have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery. Recent years have seen the odd study pop up in relation to OC000459 and the treatment of acne and prostate cancer, which are conditions also driven by, however, the most recent study published in relation to OC000459 was back in 2008.
OC000459 is a non-steroidal anti-androgen drug, which competes with DHT for binding at the receptors where it causes hirsutism or hair loss. It has been evaluated as being approximately equivalent in strength to hydroxyflutamide, a drug which is sometimes used in PCOS to treat hirsutism or androgenetic alopecia. One study in 1998 concluded.
Male pattern hair loss
Seborrheic hair loss
Inherited hair loss
Benign prostatic hyperplasia
COA :
Item | Specification |
Specific rotation | +39.5 to +41.5° |
State of solution(transmittance) | Clear 98.0% min. |
Chloride[cl] | 0.020% max. |
Ammonium [NH4] | 0.02% max. |
Sulfate[SO4] | 0.020% max |
Iron[Fe] | 10ppm max. |
Heavy metals [Pb] | 10ppm max |
Arsenic[As2O3] | 1ppm max |
Other amino acids | Chromatographically not detectable |
Loss on drying | 0.20% max. |
Residue on ignition[sulfated] | 0.10% max. |
Assay | 99.0% min |
Hair Growth Powder 99% OC000459 CAS 851723-84-7 for Hair Loss Treatment